Total: £ 56.28
Published Date: 2025-09-17 | Pages: 102 | Tables: 106 | Food & Beverages
The global Bioactive Protein and Peptides market size was US$ 1924 million in 2024 and is forecast to a readjusted size of US$ 3054 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.
Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.
The global Bioactive Protein and Peptides market is strategically segmented by company, region (country), by Source, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Source, and by Application for 2020-2031.
Market Segmentation
By Company:
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Reborn Biotech
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
By Type: (Dominant Segment vs High-Margin Innovation)
Plant Source
Animal Source
By Application: (Core Demand Driver vs Emerging Opportunity)
Functional Food
Dietary Supplements
Personal Care
Animal Nutrition
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Gelita in Europe)
- Emerging Product Trends: Plant Source adoption vs. Animal Source premiumization
- Demand-Side Dynamics: Functional Food growth in China vs. Dietary Supplements potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Bioactive Protein and Peptides market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Animal Source in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Dietary Supplements in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Bioactive Protein and Peptides value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Source
1.2.1 Global Market Size Growth by Source: 2020 VS 2024 VS 2031
1.2.2 Plant Source
1.2.3 Animal Source
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Functional Food
1.3.3 Dietary Supplements
1.3.4 Personal Care
1.3.5 Animal Nutrition
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioactive Protein and Peptides Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Bioactive Protein and Peptides Revenue Market Share by Region (2020-2025)
2.4 Global Bioactive Protein and Peptides Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Bioactive Protein and Peptides Market Size and Prospective (2020-2031)
2.5.2 Europe Bioactive Protein and Peptides Market Size and Prospective (2020-2031)
2.5.3 China Bioactive Protein and Peptides Market Size and Prospective (2020-2031)
2.5.4 Japan Bioactive Protein and Peptides Market Size and Prospective (2020-2031)
3 Breakdown Data by Source
3.1 Global Bioactive Protein and Peptides Historic Market Size by Source (2020-2025)
3.2 Global Bioactive Protein and Peptides Forecasted Market Size by Source (2026-2031)
3.3 Different Types Bioactive Protein and Peptides Representative Players
4 Breakdown Data by Application
4.1 Global Bioactive Protein and Peptides Historic Market Size by Application (2020-2025)
4.2 Global Bioactive Protein and Peptides Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Bioactive Protein and Peptides Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Bioactive Protein and Peptides Players by Revenue (2020-2025)
5.1.2 Global Bioactive Protein and Peptides Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Bioactive Protein and Peptides Revenue
5.4 Global Bioactive Protein and Peptides Market Concentration Analysis
5.4.1 Global Bioactive Protein and Peptides Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Bioactive Protein and Peptides Revenue in 2024
5.5 Global Key Players of Bioactive Protein and Peptides Head office and Area Served
5.6 Global Key Players of Bioactive Protein and Peptides, Product and Application
5.7 Global Key Players of Bioactive Protein and Peptides, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Bioactive Protein and Peptides Revenue by Company (2020-2025)
6.1.2 North America Market Size by Source
6.1.2.1 North America Bioactive Protein and Peptides Market Size by Source (2020-2025)
6.1.2.2 North America Bioactive Protein and Peptides Market Share by Source (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Bioactive Protein and Peptides Market Size by Application (2020-2025)
6.1.3.2 North America Bioactive Protein and Peptides Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Bioactive Protein and Peptides Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Source
6.2.2.1 Europe Bioactive Protein and Peptides Market Size by Source (2020-2025)
6.2.2.2 Europe Bioactive Protein and Peptides Market Share by Source (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Bioactive Protein and Peptides Market Size by Application (2020-2025)
6.2.3.2 Europe Bioactive Protein and Peptides Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Bioactive Protein and Peptides Revenue by Company (2020-2025)
6.3.2 China Market Size by Source
6.3.2.1 China Bioactive Protein and Peptides Market Size by Source (2020-2025)
6.3.2.2 China Bioactive Protein and Peptides Market Share by Source (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Bioactive Protein and Peptides Market Size by Application (2020-2025)
6.3.3.2 China Bioactive Protein and Peptides Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Bioactive Protein and Peptides Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Source
6.4.2.1 Japan Bioactive Protein and Peptides Market Size by Source (2020-2025)
6.4.2.2 Japan Bioactive Protein and Peptides Market Share by Source (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Bioactive Protein and Peptides Market Size by Application (2020-2025)
6.4.3.2 Japan Bioactive Protein and Peptides Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Gelita
7.1.1 Gelita Company Details
7.1.2 Gelita Business Overview
7.1.3 Gelita Bioactive Protein and Peptides Introduction
7.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.1.5 Gelita Recent Development
7.2 Kerry Group
7.2.1 Kerry Group Company Details
7.2.2 Kerry Group Business Overview
7.2.3 Kerry Group Bioactive Protein and Peptides Introduction
7.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.2.5 Kerry Group Recent Development
7.3 Vital Proteins
7.3.1 Vital Proteins Company Details
7.3.2 Vital Proteins Business Overview
7.3.3 Vital Proteins Bioactive Protein and Peptides Introduction
7.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.3.5 Vital Proteins Recent Development
7.4 Rousselot
7.4.1 Rousselot Company Details
7.4.2 Rousselot Business Overview
7.4.3 Rousselot Bioactive Protein and Peptides Introduction
7.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.4.5 Rousselot Recent Development
7.5 BRF Ingredients
7.5.1 BRF Ingredients Company Details
7.5.2 BRF Ingredients Business Overview
7.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction
7.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.5.5 BRF Ingredients Recent Development
7.6 Bunge Ltd
7.6.1 Bunge Ltd Company Details
7.6.2 Bunge Ltd Business Overview
7.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction
7.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.6.5 Bunge Ltd Recent Development
7.7 Ingredia Nutritional
7.7.1 Ingredia Nutritional Company Details
7.7.2 Ingredia Nutritional Business Overview
7.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction
7.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.7.5 Ingredia Nutritional Recent Development
7.8 Gelatines Weishardt
7.8.1 Gelatines Weishardt Company Details
7.8.2 Gelatines Weishardt Business Overview
7.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction
7.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.8.5 Gelatines Weishardt Recent Development
7.9 PanTheryx
7.9.1 PanTheryx Company Details
7.9.2 PanTheryx Business Overview
7.9.3 PanTheryx Bioactive Protein and Peptides Introduction
7.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.9.5 PanTheryx Recent Development
7.10 Hubei Reborn Biotech
7.10.1 Hubei Reborn Biotech Company Details
7.10.2 Hubei Reborn Biotech Business Overview
7.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction
7.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.10.5 Hubei Reborn Biotech Recent Development
7.11 Seagarden
7.11.1 Seagarden Company Details
7.11.2 Seagarden Business Overview
7.11.3 Seagarden Bioactive Protein and Peptides Introduction
7.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.11.5 Seagarden Recent Development
7.12 Shandong Hengxin Biotech
7.12.1 Shandong Hengxin Biotech Company Details
7.12.2 Shandong Hengxin Biotech Business Overview
7.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction
7.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.12.5 Shandong Hengxin Biotech Recent Development
7.13 Baotou Dongbao Bio-Tech
7.13.1 Baotou Dongbao Bio-Tech Company Details
7.13.2 Baotou Dongbao Bio-Tech Business Overview
7.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction
7.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.13.5 Baotou Dongbao Bio-Tech Recent Development
7.14 Wuhan Jiushengtang Biotech
7.14.1 Wuhan Jiushengtang Biotech Company Details
7.14.2 Wuhan Jiushengtang Biotech Business Overview
7.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction
7.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.14.5 Wuhan Jiushengtang Biotech Recent Development
7.15 Morinaga Milk
7.15.1 Morinaga Milk Company Details
7.15.2 Morinaga Milk Business Overview
7.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction
7.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.15.5 Morinaga Milk Recent Development
7.16 Collagile
7.16.1 Collagile Company Details
7.16.2 Collagile Business Overview
7.16.3 Collagile Bioactive Protein and Peptides Introduction
7.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.16.5 Collagile Recent Development
7.17 Nuritas
7.17.1 Nuritas Company Details
7.17.2 Nuritas Business Overview
7.17.3 Nuritas Bioactive Protein and Peptides Introduction
7.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.17.5 Nuritas Recent Development
7.18 SmartPEP
7.18.1 SmartPEP Company Details
7.18.2 SmartPEP Business Overview
7.18.3 SmartPEP Bioactive Protein and Peptides Introduction
7.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2020-2025)
7.18.5 SmartPEP Recent Development
8 Bioactive Protein and Peptides Market Dynamics
8.1 Bioactive Protein and Peptides Industry Trends
8.2 Bioactive Protein and Peptides Market Drivers
8.3 Bioactive Protein and Peptides Market Challenges
8.4 Bioactive Protein and Peptides Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Bioactive Protein and Peptides Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Bioactive Protein and Peptides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Bioactive Protein and Peptides Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Bioactive Protein and Peptides Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Bioactive Protein and Peptides Revenue Share by Region (2020-2025)
Table 6. Global Bioactive Protein and Peptides Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Bioactive Protein and Peptides Revenue Share Forecast by Region (2026-2031)
Table 8. Global Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 9. Global Bioactive Protein and Peptides Revenue Market Share by Source (2020-2025)
Table 10. Global Bioactive Protein and Peptides Forecasted Market Size by Source (2026-2031) & (US$ Million)
Table 11. Global Bioactive Protein and Peptides Revenue Market Share by Source (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Bioactive Protein and Peptides Revenue Market Share by Application (2020-2025)
Table 15. Global Bioactive Protein and Peptides Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Bioactive Protein and Peptides Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Bioactive Protein and Peptides Application
Table 18. Global Bioactive Protein and Peptides Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Bioactive Protein and Peptides Market Share by Players (2020-2025)
Table 20. Global Top Bioactive Protein and Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2024)
Table 21. Ranking of Global Top Bioactive Protein and Peptides Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Bioactive Protein and Peptides Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Bioactive Protein and Peptides, Headquarters and Area Served
Table 24. Global Key Players of Bioactive Protein and Peptides, Product and Application
Table 25. Global Key Players of Bioactive Protein and Peptides, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Bioactive Protein and Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Bioactive Protein and Peptides Revenue Market Share by Company (2020-2025)
Table 29. North America Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 30. North America Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Bioactive Protein and Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Bioactive Protein and Peptides Revenue Market Share by Company (2020-2025)
Table 33. Europe Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 34. Europe Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Bioactive Protein and Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Bioactive Protein and Peptides Revenue Market Share by Company (2020-2025)
Table 37. China Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 38. China Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Bioactive Protein and Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Bioactive Protein and Peptides Revenue Market Share by Company (2020-2025)
Table 41. Japan Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 42. Japan Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 43. Gelita Company Details
Table 44. Gelita Business Overview
Table 45. Gelita Bioactive Protein and Peptides Product
Table 46. Gelita Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 47. Gelita Recent Development
Table 48. Kerry Group Company Details
Table 49. Kerry Group Business Overview
Table 50. Kerry Group Bioactive Protein and Peptides Product
Table 51. Kerry Group Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 52. Kerry Group Recent Development
Table 53. Vital Proteins Company Details
Table 54. Vital Proteins Business Overview
Table 55. Vital Proteins Bioactive Protein and Peptides Product
Table 56. Vital Proteins Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 57. Vital Proteins Recent Development
Table 58. Rousselot Company Details
Table 59. Rousselot Business Overview
Table 60. Rousselot Bioactive Protein and Peptides Product
Table 61. Rousselot Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 62. Rousselot Recent Development
Table 63. BRF Ingredients Company Details
Table 64. BRF Ingredients Business Overview
Table 65. BRF Ingredients Bioactive Protein and Peptides Product
Table 66. BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 67. BRF Ingredients Recent Development
Table 68. Bunge Ltd Company Details
Table 69. Bunge Ltd Business Overview
Table 70. Bunge Ltd Bioactive Protein and Peptides Product
Table 71. Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 72. Bunge Ltd Recent Development
Table 73. Ingredia Nutritional Company Details
Table 74. Ingredia Nutritional Business Overview
Table 75. Ingredia Nutritional Bioactive Protein and Peptides Product
Table 76. Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 77. Ingredia Nutritional Recent Development
Table 78. Gelatines Weishardt Company Details
Table 79. Gelatines Weishardt Business Overview
Table 80. Gelatines Weishardt Bioactive Protein and Peptides Product
Table 81. Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 82. Gelatines Weishardt Recent Development
Table 83. PanTheryx Company Details
Table 84. PanTheryx Business Overview
Table 85. PanTheryx Bioactive Protein and Peptides Product
Table 86. PanTheryx Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 87. PanTheryx Recent Development
Table 88. Hubei Reborn Biotech Company Details
Table 89. Hubei Reborn Biotech Business Overview
Table 90. Hubei Reborn Biotech Bioactive Protein and Peptides Product
Table 91. Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 92. Hubei Reborn Biotech Recent Development
Table 93. Seagarden Company Details
Table 94. Seagarden Business Overview
Table 95. Seagarden Bioactive Protein and Peptides Product
Table 96. Seagarden Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 97. Seagarden Recent Development
Table 98. Shandong Hengxin Biotech Company Details
Table 99. Shandong Hengxin Biotech Business Overview
Table 100. Shandong Hengxin Biotech Bioactive Protein and Peptides Product
Table 101. Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 102. Shandong Hengxin Biotech Recent Development
Table 103. Baotou Dongbao Bio-Tech Company Details
Table 104. Baotou Dongbao Bio-Tech Business Overview
Table 105. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product
Table 106. Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 107. Baotou Dongbao Bio-Tech Recent Development
Table 108. Wuhan Jiushengtang Biotech Company Details
Table 109. Wuhan Jiushengtang Biotech Business Overview
Table 110. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product
Table 111. Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 112. Wuhan Jiushengtang Biotech Recent Development
Table 113. Morinaga Milk Company Details
Table 114. Morinaga Milk Business Overview
Table 115. Morinaga Milk Bioactive Protein and Peptides Product
Table 116. Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 117. Morinaga Milk Recent Development
Table 118. Collagile Company Details
Table 119. Collagile Business Overview
Table 120. Collagile Bioactive Protein and Peptides Product
Table 121. Collagile Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 122. Collagile Recent Development
Table 123. Nuritas Company Details
Table 124. Nuritas Business Overview
Table 125. Nuritas Bioactive Protein and Peptides Product
Table 126. Nuritas Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 127. Nuritas Recent Development
Table 128. SmartPEP Company Details
Table 129. SmartPEP Business Overview
Table 130. SmartPEP Bioactive Protein and Peptides Product
Table 131. SmartPEP Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 132. SmartPEP Recent Development
Table 133. Bioactive Protein and Peptides Market Trends
Table 134. Bioactive Protein and Peptides Market Drivers
Table 135. Bioactive Protein and Peptides Market Challenges
Table 136. Bioactive Protein and Peptides Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Bioactive Protein and Peptides Product Picture
Figure 2. Global Bioactive Protein and Peptides Market Share by Source: 2024 VS 2031
Figure 3. Plant Source Features
Figure 4. Animal Source Features
Figure 5. Global Bioactive Protein and Peptides Market Share by Application: 2024 VS 2031
Figure 6. Functional Food
Figure 7. Dietary Supplements
Figure 8. Personal Care
Figure 9. Animal Nutrition
Figure 10. Other
Figure 11. Bioactive Protein and Peptides Report Years Considered
Figure 12. Global Bioactive Protein and Peptides Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Bioactive Protein and Peptides Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Bioactive Protein and Peptides Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Bioactive Protein and Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Bioactive Protein and Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Bioactive Protein and Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Bioactive Protein and Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Bioactive Protein and Peptides Market Share by Players in 2024
Figure 20. Global Top Bioactive Protein and Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Bioactive Protein and Peptides Revenue in 2024
Figure 22. North America Bioactive Protein and Peptides Market Share by Source (2020-2025)
Figure 23. North America Bioactive Protein and Peptides Market Share by Application (2020-2025)
Figure 24. Europe Bioactive Protein and Peptides Market Share by Source (2020-2025)
Figure 25. Europe Bioactive Protein and Peptides Market Share by Application (2020-2025)
Figure 26. China Bioactive Protein and Peptides Market Share by Source (2020-2025)
Figure 27. China Bioactive Protein and Peptides Market Share by Application (2020-2025)
Figure 28. Japan Bioactive Protein and Peptides Market Share by Source (2020-2025)
Figure 29. Japan Bioactive Protein and Peptides Market Share by Application (2020-2025)
Figure 30. Gelita Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 31. Kerry Group Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 32. Vital Proteins Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 33. Rousselot Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 34. BRF Ingredients Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 35. Bunge Ltd Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 36. Ingredia Nutritional Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 37. Gelatines Weishardt Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 38. PanTheryx Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 39. Hubei Reborn Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 40. Seagarden Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 41. Shandong Hengxin Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 42. Baotou Dongbao Bio-Tech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 43. Wuhan Jiushengtang Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 44. Morinaga Milk Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 45. Collagile Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 46. Nuritas Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 47. SmartPEP Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed